Literature DB >> 3216316

Oral defense mechanisms are impaired early in HIV-1 infected patients.

C K Yeh1, P C Fox, J A Ship, K A Busch, D K Bermudez, A M Wilder, R W Katz, A Wolff, C A Tylenda, J C Atkinson.   

Abstract

We have examined the hypothesis that individuals infected with human immune deficiency virus type 1 (HIV-1) experience significant, specific alterations in mechanisms protecting the oral cavity prior to the appearance of AIDS-related systemic opportunistic infections. In a study of 13 early-stage, stable anti-HIV antibody positive patients, parotid salivary function was found to be generally intact. In contrast, several indicators of submandibular gland dysfunction were detected. In particular, stimulated fluid output was decreased and salivary lysozyme levels were increased relative to controls by 50-60% for both resting (p less than 0.05) and stimulated (p less than 0.001) conditions. Also, the frequency of albumin detection in submandibular saliva samples was approximately 65% in HIV-1 infected patients vs. 0% in controls (p less than 0.05). In addition, cytologic evaluation of oral mucosa revealed a fivefold increase in the prevalence of candidal hyphae in HIV-1 infected patients compared to controls (41% vs. 8%, p less than 0.05). We conclude that normal oral defense mechanisms show signs of compromise in HIV-1 infected individuals. We suggest that (a) effects of HIV-1 infection are seen early in the oral cavity, (b) impairment of oral defense mechanisms may facilitate entry of microorganisms with an attendant increased risk of morbidity and mortality, and (c) intensive oral surveillance and prophylactic care should be part of the routine management afforded to AIDS patients soon after HIV-1 infection is recognized.

Entities:  

Mesh:

Year:  1988        PMID: 3216316

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  10 in total

1.  Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting.

Authors:  J Schmid; F C Odds; M J Wiselka; K G Nicholson; D R Soll
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Oral and esophageal Candida albicans infection in hyposalivatory rats.

Authors:  S W Meitner; W H Bowen; C G Haidaris
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

Review 3.  Oral innate immunity in HIV infection in HAART era.

Authors:  Wipawee Nittayananta; Renchuan Tao; Lanlan Jiang; Yuanyuan Peng; Yuxiao Huang
Journal:  J Oral Pathol Med       Date:  2015-01-31       Impact factor: 4.253

4.  Further characterization of human salivary anticandidal activities in a human immunodeficiency virus-positive cohort by use of microassays.

Authors:  A L Lin; Q Shi; D A Johnson; T F Patterson; M G Rinaldi; C K Yeh
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.

Authors:  Y H Samaranayake; L P Samaranayake; E H Pow; V T Beena; K W Yeung
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease.

Authors:  Virginia A Carroll; Alyssa Lundgren; Hairong Wei; Susan Sainz; Kenneth S Tung; Michael G Brown
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 7.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).

Authors:  M Navazesh; R Mulligan; R Karim; W J Mack; S Ram; H Seirawan; J Greenspan; D Greenspan; J Phelan; M Alves
Journal:  Oral Dis       Date:  2008-11-11       Impact factor: 3.511

Review 9.  Oral diseases in HIV-1 infection.

Authors:  C E Barr
Journal:  Dysphagia       Date:  1992       Impact factor: 3.438

10.  Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients.

Authors:  Yuta Takahashi; Naoyoshi Nagata; Takuro Shimbo; Takeshi Nishijima; Koji Watanabe; Tomonori Aoki; Katsunori Sekine; Hidetaka Okubo; Kazuhiro Watanabe; Toshiyuki Sakurai; Chizu Yokoi; Masao Kobayakawa; Hirohisa Yazaki; Katsuji Teruya; Hiroyuki Gatanaga; Yoshimi Kikuchi; Sohtaro Mine; Toru Igari; Yuko Takahashi; Akio Mimori; Shinichi Oka; Junichi Akiyama; Naomi Uemura
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.